Study on polymorphisms of cardiac potassium channel gene and susceptibility of malignant arrhythmia population

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052006

Enrollment

Unknown

Registered

2021-10-12

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant arrhythmia

Interventions

Malignant arrhythmia group vs normal group:No

Eligibility

Sex/Gender

All

Age

No minimum to 100 Years

Inclusion criteria

Inclusion criteria: Malignant arrhythmia group: 1. The patient himself is diagnosed with arrhythmia diseases, such as LQTS, SQTS, IVF, BrS, CPVT, CCD, etc.; 2. The patient and his immediate family have arrhythmia and a history of syncope or someone in the family SAD has occurred; 3. The sample type is the patient's blood sample, as well as the blood and tissue samples from the deceased. Control group: 1. Healthy volunteers and their immediate family members have no ECG abnormalities, and no history of MA, syncope and SAD in the family; 2. Autopsy cases with non-sudden cardiac death and no arrhythmic diseases.

Exclusion criteria

Exclusion criteria: Disagree with participants.

Design outcomes

Primary

Measure	Time frame
Cardiac ion channel gene;	—

Countries

China

Contacts

Public ContactChen Deqing

Jiaxing University

dqchen@zjxu.edu.cn+86 18969335518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026